Evidence map›Paper›PMID 41456498›Full record

ArticleInternational journal of oncology2026

[Retracted] Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF‑7 breast cancer cells.

Rubí Viedma-Rodriguez, Luis Arturo Baiza-Gutman, Alejandro García-Carrancá, Leticia Moreno-Fierros, Fabio Salamanca-Gómez, Diego Arenas-Aranda

Abstract readRetraction Notice
In one paragraph

Article in International journal of oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Rubí Viedma-RodriguezUnit of Medical Research in Human Genetics, Medical National Center, Century XXI, Mexican Institute of Social Insurance, Mexico City 06729, Mexico.
Luis Arturo Baiza-GutmanMorphophysiology and Function Unit, Faculty of Higher Studies Iztacala, National Autonomous University of Mexico, Iztacala, Mexico 54090, Mexico.
Alejandro García-CarrancáCancer Biomedical Research Unit, National Cancer Institute and Biomedical Research Institute, National Autonomous University of Mexico, Mexico City 14080, Mexico.
Leticia Moreno-FierrosBiomedicine Unit, Faculty of Higher Studies Iztacala, National Autonomous University of Mexico, Iztacala, Mexico city 54090, Mexico.
Fabio Salamanca-GómezUnit of Medical Research in Human Genetics, Medical National Center, Century XXI, Mexican Institute of Social Insurance, Mexico City 06729, Mexico.
Diego Arenas-ArandaUnit of Medical Research in Human Genetics, Medical National Center, Century XXI, Mexican Institute of Social Insurance, Mexico City 06729, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above paper, a concerned reader drew to the Editor's attention that, in Fig. 6, the same data appeared to have been included in three of the flow cytometric plots featured in this figure (for the Non‑treated, Scrambled and SiRNAi BIK experiments). Moreover, the control β‑actin western blots in Figs. 2B, 4A and 8B appeared to be the same (although, in these cases, the lanes for the blots were labelled up identically, and so these apparent duplications may not have represented an incorrect assembly of these figures); similarly, the control blots in Fig. 7A and B were also matching. However, the control β‑actin western blots in three other figure parts (Fig. 1C and 7A/B) were also duplicated, and in this case, the numbers of lanes in the gel slices were different / the lanes were labelled differently. The authors were contacted by the Editorial Office to offer an explanation for these potential anomalies in the presentation of the data in this paper, although up to this time, no response from them has been forthcoming. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, the Editor of

Indexed as

apoptosisBIKbreast cancertamoxifen

Identifiers

PMID41456498
PMCPMC12823054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.